Number of test report issued by that service:

(Return tabled) Question No. 1123 Ms. Kirsty Duncan: With respect to the government’s position on chronic cerebrospinal venous insufficiency (CCSVI): (a) does the government track clinical trials on CCSVI currently being undertaken by other countries and, if yes, what are all clinical trials, identified by phase, currently being undertaken worldwide, (i) which countries are undertaking Phase lll trials; (b) does the government question whether CCSVI exists and, if yes, (i) why does the government not question whether treating CCSVI actually improves quality of life for Canadians with multiple sclerosis (MS); (c) how many cases of " major complications associated with venous angioplasty" have occurred in Canada and, if it is not possible ...[+++]to give this number, why, (i) what are identified complications to CCSVI and, for each complication, how many cases versus the number of procedures undertaken have occurred; (d) what are all procedures that have been performed on veins in Canada, including, procedures for Budd-Chiari syndrome and May-Thurner syndrome; (e) what is the government's position on ballooning veins and why does it consider that ballooning veins even once could be unsafe on fragile veins, even though participants involved in the proposed clinical trial will experience two procedures-one real, one simulated-in a one-year period; (f) is the government consulting with Canadians with MS, if so, (i) provide a list of all CCSVI groups the Minister of Health has met with along with the dates of the meetings, (ii) provide a list of all MS groups the Minister of Health has met with along with the dates of the meetings, (iii) provide the number of Canadians with MS the Minister of Health has met and the dates of all meetings, and if the government is not consulting, (iv) why not; (g) how does inviting the investigators of the seven MS-funded CCSVI studies to participate in the consensus workshop on ultrasound imaging meet CIHR's conflict of interest g ...

(Return tabled) Question No. 520 Mr. Peter Stoffer: With regard to the disability pensions awarded by Veterans Affairs Canada under the Pension Act and the lump sum payments issued by the Canadian Forces Members and Veterans Re-Establishment and Compensation Act (New Veterans Charter): (a) what is the total number of disability pensions, broken down by type of service-related disability; (b) what is the total number of lump-sum payments, broken down by type of service-related disability; (c) what percentage of all disability pensions are issued for service-related disabilities as outlined in (a); (d) does Veterans Affairs Canada inform the Department of National Defence of the high incidence of certain occupational/service-related injuri ...[+++]es and payments awarded by Veterans Affairs Canada per calendar year; (e) how many disability pensions under the Pensions Act have been awarded each year from 2006 inclusive to 2012, for (i) Agent Orange exposure, (ii) atomic veterans, including those who participated in nuclear weapons tests in the United States (US) and Chalk River decontamination efforts, (iii) exposure to asbestos, (iv) exposure to depleted uranium; (f) how many payments under the New Veterans Charter have been awarded each year from 2006 inclusive to 2012 for (i) Agent Orange exposure, (ii) atomic veterans, including those who participated in nuclear weapons tests in the US and Chalk River decontamination efforts, (iii) exposure to asbestos, (iv) exposure to depleted uranium; and (g) how many veterans under the New Veterans Charter have received the following benefits each year from 2006 inclusive to 2011 for (i) Earning Loss Benefit, (ii) Canadian Forces Income Support, (iii) Permanent Impairment Allowance, (iv) Supplementary Retirement Benefit?

To date a total of €7,485,982 has been paid to cover all aspects of development including quality assurance, acceptance testing, user helpdesk and training services.

GE, the diversified industrial corporation active in numerous fields including aircraft engines, power systems, transportation systems, industrial systems, plastics, lighting, medical systems, appliances, media, financial services, software and Internet services, also has ultrasound NDT activities which are operated as part of its US-based Panametrics subsidiary.

The only way that modern industrial production systems can develop and remain competitive is if they are backed up by recognized standards and by a reliable measurement and testing infrastructure The effective application of European policies in the industrial, agricultural, energy and services sectors calls for the use of measurement and testing methods that are accepted, recognized and respected not only in Europe but also throughout the world To ensure the best possible guarantees, the quality of life in Europe in terms of health, safety, the environment and leisure must be is based on correct and reproducible measurement and testing ...[+++]results, in order to prevent accidents and irreversible deteriorations in public health, the environment and our cultural heritage.